T. Rowe Price Associates’s Accel Entertainment ACEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427K Buy
39,122
+8,594
+28% +$96.9K ﹤0.01% 2525
2025
Q4
$349K Buy
30,528
+2,185
+8% +$23K ﹤0.01% 2564
2025
Q3
$314K Buy
28,343
+1,091
+4% +$12.8K ﹤0.01% 2584
2025
Q2
$321K Buy
27,252
+3,359
+14% +$37.5K ﹤0.01% 2501
2025
Q1
$238K Buy
23,893
+3,259
+16% +$35.5K ﹤0.01% 2560
2024
Q4
$221K Buy
20,634
+3,237
+19% +$37K ﹤0.01% 2637
2024
Q3
$203K Sell
17,397
-12,277
-41% -$135K ﹤0.01% 2642
2024
Q2
$305K Sell
29,674
-87,635
-75% -$929K ﹤0.01% 2405
2024
Q1
$1.38M Buy
117,309
+8,270
+8% +$88.2K ﹤0.01% 1748
2023
Q4
$1.12M Buy
109,039
+8,935
+9% +$92.1K ﹤0.01% 1812
2023
Q3
$1.1M Buy
100,104
+17,575
+21% +$196K ﹤0.01% 1751
2023
Q2
$872K Buy
82,529
+72,071
+689% +$677K ﹤0.01% 1874
2023
Q1
$96K Buy
+10,458
New +$94K ﹤0.01% 2692

Other funds holding ACEL

T. Rowe Price Associates's ACEL Position: Q1 2026 in Review

T. Rowe Price Associates increased its Accel Entertainment (ACEL) stake by 28% in Q1 2026, buying an estimated $96.9K and bringing the position to 39,122 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

T. Rowe Price Associates first reported a position in ACEL in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.38M in Q1 2024. 172 funds tracked by Wall St. Rank hold ACEL as of Q1 2026.

  • T. Rowe Price Associates held 39,122 shares of Accel Entertainment worth $427K as of Q1 2026.
  • T. Rowe Price Associates bought 8,594 Accel Entertainment shares in Q1 2026, an estimated $96.9K.
  • Accel Entertainment made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2525 holding.
  • T. Rowe Price Associates first reported a position in Accel Entertainment in Q1 2023 and has held it in 13 quarters since.
  • T. Rowe Price Associates's Accel Entertainment position peaked at $1.38M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Accel Entertainment as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.